Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll






Jul 18, 2013

Clinical Trial Participation

Clinical trials are absolutely necessary in order to make sure a drug works as intended. However, such testing does involve risk, as recently illustrated by Celgene’s decision to stop administering Revlimid® (lenalidomide) in its Phase III ORIGIN® trial because of patient deaths. Suppose you fit a clinical trial’s patient requirements: Would you take the risk?

If you were in a position to do so, would you participate in a clinical trial?

Yes
 
  40.2%
No
 
  17.9%
Maybe, if no other treatments worked
 
  42.0%



Related content